Risk lasts through 40 years of adulthood for underweight adolescent men.
Marijuana use also linked to worse overall semen parameters due to induction of oxidative stress.
Gynecomastia is the most common male breast disease, occurring in up to 57% of men.
11β-MNTDC is a modified testosterone with androgenic and progestational activity that is being developed as a potential male contraceptive.
A diet rich in cottonseed oil was found to improve cholesterol and triglyceride levels in healthy men.
Men who have sex with men have an increased risk of meningococcal disease, however, this risk is under-ascertained and improved surveillance is needed.
Odds of choosing screening up for men with family history, African descent, low socioeconomic status.
Men had larger reductions in metabolic syndrome Z-score, C-peptide, fat mass, heart rate.
Findings for men with intermediate- and high-risk prostate cancer
Men with higher estradiol and estradiol/testosterone levels had an increased risk for pulmonary arterial hypertension.
The USPSTF has updated its 2012 recommendations on prostate-specific antigen (PSA)-based screening for prostate cancer.
Testosterone therapy is recommended in men with hypogonadism to correct symptoms of testosterone deficiency. Men who are otherwise healthy do not need to be screened for hypogonadism.
Prostate cancer was diagnosed more frequently in men who underwent single prostate-specific antigen screening than in those who did not, but mortality was unaffected.
For men with metastatic prostate cancer, aggressive therapy has no significant advantage over conservative androgen deprivation only treatments.
A positive correlation between increased BMI and risk of prostate cancer recurrence was observed in patients undergoing radical prostatectomy.
Polygenic hazard scores were developed to help predict the age of onset of prostate cancer.
Increased ibuprofen administration elevates LH and decreases testosterone to LH and inhibin B to FSH ratios in young adult men.
Western males saw the most significant sperm count decline at 52.4%.
A 20-year study found that patients with early-stage prostate cancer who have surgery to remove their tumor do not live longer than those who receive no treatment.
The USPSTF recommends that prostate cancer screenings should be an individual decision.